Cleveland Clinic secures $10.6 m to compare multiple sclerosis treatments

(Cleveland Clinic) A Cleveland Clinic research team has attained a $10.6 million award from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of treatment options for multiple sclerosis (MS).Led by Daniel Ontaneda, M.D., a neurologist in Cleveland Clinic’s Mellen Center for Multiple Sclerosis, the project will be the first to compare two treatment options for patients recently diagnosed with the relapsing remitting form of the disease.